OPTION EXERCISE AND STOCK PURCHASE AGREEMENT INSTRUCTIONSAnd Stock Purchase Agreement • June 10th, 2005 • Avanir Pharmaceuticals • Pharmaceutical preparations • California
Contract Type FiledJune 10th, 2005 Company Industry Jurisdiction
INVESTMENT, SHAREHOLDERS’ AND STOCK PURCHASE AGREEMENT by and among THE MEN’S WEARHOUSE, INC., MOORES THE SUIT PEOPLE INC., MWUK HOLDING COMPANY LIMITED, ENSCO 648 LIMITED, GRESHAM 4A AND GRESHAM 4B and THE SELLERS SET FORTH HEREIN Dated: August 6, 2010’ and Stock Purchase Agreement • August 16th, 2010 • Mens Wearhouse Inc • Retail-apparel & accessory stores
Contract Type FiledAugust 16th, 2010 Company IndustryThis Investment, Shareholders’ and Stock Purchase Agreement (this “Agreement”) is dated as of August 6, 2010, by and among (i) The Men’s Wearhouse, Inc., a Texas corporation (“TMW”), Moores The Suit People Inc., a New Brunswick corporation (“MSP”) and MWUK Holding Company Limited (“Buyer”), a limited company incorporated in England and Wales (with registered number 07331441) and (as at the date of this Agreement), an indirect wholly-owned subsidiary of TMW, and (ii) Ensco 648 Limited, a limited liability company incorporated in England and Wales (with registered number 06474385) (the “Company”), and (iii) Gresham 4A, a limited partnership registered in England and Wales with registered number LP011407 (“Gresham 4A”) and Gresham 4B, a limited partnership registered in England and Wales with registered number LP011408 (“Gresham 4B”), acting by their manager Gresham LLP, a limited liability partnership registered in England and Wales with registered number OC307703 (“Gresham LLP”), Gresha
LIPELLA PHARMACEUTICALS INC. NOTE CANCELLATION AND STOCK PURCHASE AGREEMENTAnd Stock Purchase Agreement • November 28th, 2022 • Lipella Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
Contract Type FiledNovember 28th, 2022 Company Industry JurisdictionTHIS NOTE CANCELLATION AND STOCK PURCHASE AGREEMENT (the “Agreement”) is made as of the Effective Time (as defined herein) by and between Dr. Michael Chancellor (the “Investor”) and Lipella Pharmaceuticals Inc., a Delaware corporation (the “Company” and together with the Investor, the “Parties” or each, a “Party”). For the purposes of this Agreement, the “Effective Time” shall mean immediately prior to the consummation of the Company’s intended initial public underwritten offering.
AVANADE INC.And Stock Purchase Agreement • January 20th, 2006 • Avanade Inc. • Washington
Contract Type FiledJanuary 20th, 2006 Company Jurisdiction
EXHIBIT 12 AMENDMENT AND STOCK PURCHASE AGREEMENTAnd Stock Purchase Agreement • May 1st, 2001 • Forstmann Little & Co Sub Debt & Eq MGMT Buyout Par Vii Lp • Telephone communications (no radiotelephone) • New York
Contract Type FiledMay 1st, 2001 Company Industry Jurisdiction
Artes Medical, Inc. Artes Medical, Inc. 2006 Equity Incentive Plan OPTION EXERCISE AND STOCK PURCHASE AGREEMENT InstructionsAnd Stock Purchase Agreement • August 7th, 2006 • Artes Medical Inc • Pharmaceutical preparations • Delaware
Contract Type FiledAugust 7th, 2006 Company Industry Jurisdiction
INVESTMENT, SHAREHOLDERS’ AND STOCK PURCHASE AGREEMENT by and among THE MEN’S WEARHOUSE, INC., MOORES THE SUIT PEOPLE INC., MWUK HOLDING COMPANY LIMITED, ENSCO 648 LIMITED, GRESHAM 4A AND GRESHAM 4B and THE SELLERS SET FORTH HEREIN Dated: August 6, 2010’ and Stock Purchase Agreement • August 10th, 2010 • Mens Wearhouse Inc • Retail-apparel & accessory stores
Contract Type FiledAugust 10th, 2010 Company IndustryThis Investment, Shareholders’ and Stock Purchase Agreement (this “Agreement”) is dated as of August 6, 2010, by and among (i) The Men’s Wearhouse, Inc., a Texas corporation (“TMW”), Moores The Suit People Inc., a New Brunswick corporation (“MSP”) and MWUK Holding Company Limited (“Buyer”), a limited company incorporated in England and Wales (with registered number 07331441) and (as at the date of this Agreement), an indirect wholly-owned subsidiary of TMW, and (ii) Ensco 648 Limited, a limited liability company incorporated in England and Wales (with registered number 06474385) (the “Company”), and (iii) Gresham 4A, a limited partnership registered in England and Wales with registered number LP011407 (“Gresham 4A”) and Gresham 4B, a limited partnership registered in England and Wales with registered number LP011408 (“Gresham 4B”), acting by their manager Gresham LLP, a limited liability partnership registered in England and Wales with registered number OC307703 (“Gresham LLP”), Gresha